Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

Marie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, Julie Westerlin Kjeldsen, Magnus Pedersen, Christina Friese, Thomas Hasselager, Henrik Lajer, George Coukos, Michal Bassani-Sternberg, Marco Donia, Inge Marie Svane. Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer. British Journal of Cancer. 2019 Feb;120(4):424-434. doi: 10.1038/s41416-019-0384-y. Epub 2019 Feb 5.

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer

Tuyaerts, S., Rombauts, K., Everaert, T., Van Nuffel, AMT. and Amant, F. (2019). A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer. Front. Nutr. 5:138. doi: 10.3389/fnut.2018.00138

The Anticancer Fund becomes a Public Utility Foundation

ReDO_DB: the repurposing drugs in oncology database

Pantziarka, P., Verbaanderd, C., Sukhatme, V., Capistrano, R., Crispino, S. Gyawali, B., Rooman, I., Van Nuffel, A. MT., Meheus, L., Sukhatme, V. P., & Bouche, G. (2018). ReDO_DB: the repurposing drugs in oncology database. Ecancermedicalscience, 12, 886. https://doi.org/10.3332/ecancer.2018.886

Intraoperative ketorolac in high-risk breast cancer patients with and without inflammation

presented at San Antonio Breast Cancer Symposium 2018

KETOROLAC poster presented at the San Antonio Breast Cancer Symposium

Positive preliminary results for innovative treatment against killer brain cancer glioblastoma.

Drug Repurposing as a Source of Innovative Therapies in Chondrosarcoma

presented on CTOS 2018 by our colleague Pan Pantziarka